Treatment FAQ

what is the most common drug treatment prescribed for her2+ (er-) tumors?

by Rod Miller Published 3 years ago Updated 2 years ago

If a tumor is HER2-positive, the HER2-targeted therapy drug trastuzumab

Trastuzumab

Trastuzumab is used alone or with other medications to treat certain types of breast cancer. It is also used along with other medications to treat certain types of stomach cancer. The types of cancers trastuzumab is used to treat are tumors that produce more than the normal amount of a certain substance called HER2 protein.

(Herceptin) is included in the chemotherapy regimen. Sometimes other drugs that target HER2 are used. Pertuzumab (Perjeta) can be combined with trastuzumab and neratinib (Nerlynx) can be given after trastuzumab.

ER+/HER2- is the most common type of breast cancer; it is traditionally treated with therapies like tamoxifen or letrozole that target the hormone receptor pathway. "Ibrance is the first drug in its class to be approved by the FDA," said Dr.Feb 3, 2015

Full Answer

What are the treatment options for HER2+ breast cancer?

Most common: neoadjuvant chemotherapy plus HER2-targeted therapy. Most people with HER2+ breast cancer, including those with very small tumors, use this plan. After surgery, they’ll get adjuvant therapy with HER2-targeted therapy. Less common: surgery, followed by adjuvant treatment with chemotherapy and HER2-directed therapy.

What was the first drug approved to treat HER2-positive cancer?

In 1998, Herceptin (trastuzumab), the first medication to directly target HER2, was approved by the FDA. Oncologists usually start with this drug before trying other treatments. In the decade following its advent, Herceptin was joined by two more HER2-targeted therapies: Perjeta (pertuzumab) and T-DM1 (trastuzumab emtansine).

What are Her2 inhibitors?

Human epidermal growth factor receptor (HER2) inhibitors are either tyrosine kinase inhibitors or monoclonal antibodies that slow down or stop cell growth.

Which anti-HER2 therapies are being used in HR+ cancers?

Novel anti-HER2 therapies, including neratinib and trastuzumab emtansine, and new agents that are effective in HR+ cancers, including the next generation of oral selective estrogen receptor downregulators/degraders and CDK4/6 inhibitors such as palbociclib, are now being evaluated in combination.

What is the most effective treatment for HER2-positive breast cancer?

Trastuzumab is given intravenously (with an IV) weekly or every 3 weeks. As an adjuvant therapy, one year of treatment of treatment is typical. Multiple studies show that trastuzumab can dramatically improve survival. In fact, trastuzumab-based treatments for HER2+ breast cancer are considered the gold standard.

What medication is used for HER2-positive breast cancer?

Neratinib is used to treat HER2-positive early breast cancer in some women who have completed treatment with trastuzumab (Herceptin). Treatment with neratinib may reduce the risk of breast cancer recurrence in some people [146]. Neratinib is a pill taken every day for one year.

What chemo drugs are used for HER2-negative breast cancer?

Olaparib and talazoparib can be used to treat advanced or metastatic, HER2-negative breast cancer in women with a BRCA mutation who have already had chemotherapy. If the cancer is hormone receptor-positive, olaparib can also be used in women who have already received hormone therapy.

What drugs target HER2-positive?

Herceptin (chemical name: trastuzumab) is used to treat both early-stage and advanced HER2-positive breast cancer and can be given with chemotherapy and sometimes another targeted therapy called Perjeta (chemical name: pertuzumab).

What is the 5 year pill for breast cancer?

Tamoxifen. Tamoxifen is usually taken daily in pill form. It's often used to reduce the risk of cancer recurrence in women who have been treated for early-stage breast cancer. In this situation, it's typically taken for five to 10 years.

What is the survival rate of HER2-positive breast cancer?

But new treatments like chemotherapy plus trastuzumab have boosted early-stage HER2 positive breast cancer survival rates: 7-year disease-free: Around 93% 10-year disease-free: About 70%-75% Overall: 80%-85%

What is the most common chemo drug for breast cancer?

Chemotherapy drugs used for breast cancerAnthracyclines, such as doxorubicin (Adriamycin) and epirubicin (Ellence)Taxanes, such as paclitaxel (Taxol) and docetaxel (Taxotere)5-fluorouracil (5-FU) or capecitabine (Xeloda)Cyclophosphamide (Cytoxan)Carboplatin (Paraplatin)

What is the new drug for breast cancer?

In March 2019 , the FDA approved atezolizumab (Tecentriq), a new type of drug known as a PD-L1 inhibitor. Atezolizumab is approved for people with locally advanced or metastatic triple-negative breast cancer (TNBC) that can't be surgically removed, or whose tumors express a protein called PD-L1.

What is the survival rate of HER2-negative breast cancer?

Survival rates can vary based off of the subtype of breast cancer that you have. A publication from the American Cancer Society reports 5-year survival rates for HER2-negative breast cancers as: 92 percent for HER2-negative, HR-positive breast cancer. 77 percent for triple-negative breast cancer.

Is Herceptin ever given without chemo?

Certain women age 70 to 80 may be able to skip chemotherapy after surgery for early-stage HER2-positive disease and be treated only with Herceptin (chemical name: trastuzumab), according to a study. The research was published online on Sept. 16, 2020, by the Journal of Clinical Oncology.

What are alternatives to Herceptin?

Letrozole.Ibrance.Femara.Faslodex.Xeloda.Fulvestrant.

Is Herceptin chemo or immunotherapy?

No, Herceptin is not a chemo drug, it is a targeted therapy anticancer drug. Anticancer drugs can be divided into different groups: targeted therapy. chemotherapy (often called chemo)

What is the treatment for HER2?

Trastuzumab and hyaluronidase (Herceptin Hylecta) is another type of trastuzumab treatment that is injected underneath the skin. Pertuzumab (Perjeta) treats HER2-positive early breast cancer, usually in combination with trastuzumab and chemotherapy. It’s FDA-approved for neoadjuvant and adjuvant treatment.

How to treat HER2 positive breast cancer?

Treatment for early-stage HER2-positive breast cancer will likely include some combination of surgery, targeted therapy, chemotherapy, and possibly other therapies. What’s right for you will depend on your wants and needs. There are three typical treatment strategies:

How long does it take for estrogen to work after breast cancer surgery?

One day you’ll get the treatment, and then you’ll wait 14 or 21 days for the next treatment. This gives your body a chance to recover from the side effects. As an adjuvant therapy, expect to start within 4 to 6 weeks of surgery. Endocrine therapy. More than half of breast cancers feed on estrogen to grow.

What is the drug that is given under the skin?

For people who are receiving a combination of targeted therapy, the drug trastuzumab, pertuzumab and hyaluronidase (Phesgo) may be given as a shot under the skin. Targeted Therapy: Kinase Inhibitors. Kinase inhibitors block the action of HER2 and other kinase proteins that help cancer cells grow.

What is the HER2 subtype?

About one in five people with breast cancer have the HER2+ subtype. If your breast cancer is of the HER2+ subtype, your tumor has high levels of a protein called human epidermal growth factor receptor 2 (HER2). HER2 plays a role in the growth of cancer cells, which is why HER2+ breast cancer tends to be aggressive.

How long after chemo can you take Herceptin?

Hormone-driven. If your cancer is hormone receptor-positive, your doctor may also offer you endocrine therapy. It’s a daily pill taken for at least 5 years after you finish chemo. Targeted Therapy: Herceptin.

Is Trastuzumab an adjuvant?

Trastuzumab is given intravenously (with an IV) weekly or every 3 weeks. As an adjuvant therapy, one year of treatment of treatment is typical.

What is the most common treatment for HER2?

Your oncology team may refer to these medications as “targeted therapy” or “HER2-directed therapy.”. Trastuzumab (Herceptin) and pertuzumab (Perjeta) are the most commonly used drugs used to treat HER2-positive breast cancer. Neratinib (Nerlynx) is another drug that is sometimes given after trastuzumab.

What to do if you have HER2?

If you have HER2-positive breast cancer, your oncology team will prescribe a combination of anticancer drugs. This treatment regimen will likely include a few different chemotherapy drugs as well as therapy that specifically targets HER2-positive breast cancers.

What does it mean when a cancer is HER2 positive?

When a cancer is HER2-positive, it means that the cancer cells make too much HER2 protein, which can cause tumors to grow more rapidly than with other forms of breast cancer. Drugs that target the HER2 proteins are the primary treatment for this type of breast cancer, given along with chemotherapy. Your oncology team may refer to these medications ...

How long does HER2 therapy last?

Herceptin alone is usually continued after chemotherapy has finished, every three weeks for a total of one year.

What cells do chemotherapy affect?

Other cells in the body, including those in the bone marrow, the lining of the mouth and gut, and the hair follicles, also grow and divide quickly. These cells may also be affected by the chemotherapy drugs and may trigger side effects.

How long does chemo last?

Chemotherapy generally lasts about three to six months. The total length of chemotherapy treatment may vary depending on the stage of breast cancer and a number of other factors.

What is chemo therapy?

What is chemotherapy? Chemotherapy, or chemo, is the use of medicines to kill cancer cells and stop new ones from growing. Cancer cells multiply very quickly, so chemotherapy drugs target cells in the body that grow and divide very quickly. Other cells in the body, including those in the bone marrow, the lining of the mouth and gut, ...

What are HER2 inhibitors?

Human epidermal growth factor receptor (HER2) inhibitors are either tyrosine kinase inhibitors or monoclonal antibodies that slow down or stop cell growth.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

What is the role of HER2 in cancer?

The HER2 protein is an important part of the pathway for cell growth and survival . HER2-targeted therapies target HER2-positive breast cancers. They are only used to treat HER2-positive breast cancers. They have no role in the treatment of HER2-negative cancers.

How to avoid heart problems with trastuzumab?

Your heart will be checked before and during treatment with trastuzumab to help ensure there are no problems. Adopting a lifestyle that includes a healthy diet, regular exercise and for those who smoke, quitting smoking are good ways to help avoid heart problems related to treatment.

How often is trastuzumab given?

Trastuzumab is given by vein (through an IV) or by injection under the skin every 3 weeks for one year. Treatment with trastuzumab may begin before breast cancer surgery (neoadjuvant therapy) or after surgery (adjuvant therapy). Trastuzumab is also used to treat HER2-positive metastatic breast cancers. Learn about neoadjuvant treatment ...

What is neratinib used for?

Neratinib is used to treat HER2-positive early breast cancer in some women who have completed treatment with trastuzumab (Herceptin). Treatment with neratinib may reduce the risk of breast cancer recurrence in some people [ 144 ]. Neratinib is a pill. Neratinib pills are taken every day for one year.

What is Ado-Trastuzumab used for?

Breast cancer treatment. Ado-trastuzumab emtansine is used to treat some women with HER2-positive breast cancer who have cancer remaining in their breast or lymph nodes after neoadjuvant (before surgery) chemotherapy [ 7 ].

How to contact Komen about neratinib?

If you or a loved one needs more information about breast health or breast cancer, call the Komen Breast Care Helpline at 1-877 GO KOMEN (1-877-465-6636).

What is a biosimilar drug?

A biosimilar drug is a “generic-like” version of a drug that contains biological products (biologics) such as antibodies or proteins. Trastuzumab is a biologic drug. There are some FDA-approved biosimilar forms of trastuzumab.

What is the most common blood thinner used to treat and prevent clots?

very common oral antibiotic used to treat a variety of infections. Coumadin/Warfarin. most common blood thinner used to treat and prevent clots; requires routine INR checks. Decadron. a common oral steroid used to help treat inflammation. Digoxin ("dig" pronounced "didge") a common treatment for atrial fibrillation.

What is the best antibiotic for cardiac arrest?

most commonly used during cardiac arrest to speed up heart rate. Azithromycin/Zithromax. a common antibiotic for less serious bacterial infections. Bacitracin. a common antibiotic ointment used when dressing wounds in the ER. Bactrim. a common oral antibiotic used to treat less serious bacterial infections.

What is the best medicine for MI?

an injectable blood thinner used to treat and prevent blood clots; also part of the recommended treatment for acute MI. hydrocodone/Norco. a common oral narcotic pain med used to treat moderate to severe pain. keflex. a common oral antibiotic used to treat a variety of infections, commonly skin infections and UTIs.

What is the name of the drug that dissolves blood clots in the brain?

tetracaine. a local anesthetic, often used in eye drop form in the ER. Tissue Plasminogen activator (tPA) the "clot buster drug" used to dissolve clots int he brain in stroke scenarios; extremely strong and potentially dangerous so its use is heavily scrutinized. Toradol/Ketorolac.

What is the best antibiotic for a bacterial infection?

Acnef. typically an IV antibiotic given to patients being admitted for a bacterial infection. Ativan/Lorazepam. typically used for anxiety and/or agitation; also used to stop an active epileptic seizure (not preventative) Atropine. most commonly used during cardiac arrest to speed up heart rate.

What hormones are used to treat breast cancer?

Hormone Therapy for Breast Cancer. Some types of breast cancer are affected by hormones, like estrogen and progesterone. The breast cancer cells have receptors (proteins) that attach to estrogen and progesterone, which helps them grow. Treatments that stop these hormones from attaching to these receptors are called hormone or endocrine therapy.

How does estrogen help with breast cancer?

Because estrogen encourages hormone receptor-positive breast cancers to grow, lowering the estrogen level can help slow the cancer’s growth or help prevent it from coming back.

How long does hormone therapy last after surgery?

Sometimes it is started before surgery (as neoadjuvant therapy). It is usually taken for at least 5 to 10 years.

How often do you give a CDK 4/6 inhibitor?

It is given by injections into the buttocks. For the first month, the shots are given 2 weeks apart. After that, they are given once a month.

Does tamoxifen cause bone loss?

In pre-menopausal women, tamoxifen can cause some bone thinning, but in post-menopausal women it often strength ens bones to some degree. The benefits of taking these drugs outweigh the risks for almost all women with hormone receptor-positive breast cancer.

Does tamoxifen help with ductal carcinoma?

For women who have been treated with breast-conserving surgery for ductal carcinoma in situ (DCIS) that is hormone receptor-positive, taking tamoxifen for 5 years lowers the chance of the DCIS coming back. It also lowers the chance of getting an invasive breast cancer in both breasts.

Can tamoxifen be used for menopause?

It can be used to treat women with breast cancer who have or have not gone through menopause. Tamoxifen can be used in several ways: In women at high risk of breast cancer, tamoxifen can be used to help lower the risk of developing breast cancer.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9